NEW YORK (GenomeWeb News) – Genomics services company Ambry Genetics said Tuesday that it has been certified to provide services at its California lab using Agilent Technologies' microarray platforms.
Ambry Genetics said it passed an assessment program to provide comparative genomic hybridization services to detect genomic copy number variations in specific genomes.
"Array comparative genomic hybridization has become the approach of choice in research settings to comprehensively identify chromosomal imbalances throughout the genome," Aaron Elliott, an Ambry Genetics R&D scientist, said in a statement.